Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

May 04, 2020

Mylan Releases "A Legacy of Impact: 2019 Global Social Responsibility Report"

Apr 28, 2020

Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada

Apr 24, 2020

Mylan to Release First Quarter 2020 Financial Results on May 11, 2020

Apr 22, 2020

Mylan Statement Regarding European Commission’s Conditional Approval of the Combination of Mylan and Pfizer’s Upjohn Division

Apr 15, 2020

Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.

Apr 08, 2020

Mylan Updates Its Efforts Regarding COVID-19

Mar 27, 2020

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept

Mar 26, 2020

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

Mar 25, 2020

Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs

Mar 25, 2020

Mylan Statement Regarding India Manufacturing Facilities

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2022 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.